Harvard Endowment’s Private Equity Trap: Can the New Chief Escape the Billions?

1. **Private Markets Hangover:** Harvard University’s $57bn endowment is grappling with a significant $7.9bn backlog in unfunded private equity commitments, reflecting a broader liquidity challenge for institutional investors who aggressively allocated to illiquid assets during the low-interest-rate era.
2. **Asset-Liability Mismatch:** The accumulation of unfunded commitments coincides with slowing distributions from private funds and rising demands for university cash, creating a critical asset-liability mismatch that highlights the risks of over-reliance on illiquid investments for operational funding.
3. **Strategic Re-evaluation:** The situation underscores a potential shift in endowment management philosophy, with increasing calls for greater liquidity, a re-evaluation of private market exposure, and a focus on robust risk management as the market navigates higher interest rates and a constrained exit environment.

***

Harvard University’s colossal $57bn endowment, a bellwether for institutional investment strategies globally, is facing a deepening “private-markets hangover” – a condition increasingly prevalent across the endowment and foundation landscape. The university’s investment arm, Harvard Management Company (HMC), is currently contending with billions of dollars in unfunded commitments to private equity funds, a stark contrast to a market environment where the university itself faces escalating demands for cash and distributions from these very funds remain sluggish.

Public records reveal a troubling trend: the backlog of unfunded commitments has surged from $4.6bn in 2017 to an anticipated $7.9bn by 2025. This substantial increase is a direct legacy of HMC’s aggressive pivot towards private capital investments over the past decade, a strategy widely adopted by large endowments seeking alpha in an era of low public market returns. People familiar with the matter indicate that this figure remains “elevated” even into the current year, suggesting persistent pressure.

“It’s really this vicious circle that they have more and more of these commitments. The distributions just have not been coming in and the unfunded commitments pile up,” explains Philip Casey, chief executive of Institutional LPs, a technology company working with endowments. This predicament encapsulates the core challenge facing many limited partners (LPs): private equity funds, by design, call capital over several years, but the current market slowdown means that the cash *returning* to LPs via exits is lagging significantly. “The question is: have they been writing cheques that they can’t cash?” Casey ponders, voicing a concern resonating across the institutional investor community. Harvard declined to comment.

While other large university endowments are also grappling with increased unfunded commitments – a natural consequence of the private equity binge of the early 2020s, fueled by cheap capital and exuberant valuations – Harvard’s backlog stands out as unusually large, according to public records. This scale amplifies the potential systemic implications of HMC’s position.

The looming reckoning for HMC will likely fall to the successor of NP “Narv” Narvekar, the endowment’s chief executive, who has reportedly informed the board of his plans to retire as early as 2027. Narvekar’s tenure, spanning over a decade, saw HMC race to catch up to the long-term investment performance of its peers, largely by embracing the “endowment model” of heavy alternative allocations. His planned departure highlights not only a leadership transition but also a potential strategic inflection point for one of the world’s most influential institutional investors. Narvekar did not respond to a request for comment.

HMC’s surge in private equity exposure coincided with a booming asset class, particularly between 2017 and 2021. However, the market has since struggled to return cash to investors amid a sharp slowdown in listings (IPOs) and acquisitions for PE portfolio companies. This industry-wide deceleration, driven by higher interest rates, increased regulatory scrutiny, and general economic uncertainty, directly impacts LPs’ liquidity.

For Harvard, a particular area of vulnerability lies within its Covid-era private equity and venture capital funds. Many of these funds invested at frothy, elevated valuations during periods of unprecedented liquidity and market optimism. Now, in a tighter monetary environment, these investments may find it considerably harder to achieve profitable exits, potentially weighing heavily on future distributions and overall returns for the endowment. This challenge is not unique to Harvard; it’s a common pain point for LPs with significant exposure to vintage 2020-2022 private market funds.

It’s crucial to understand that such commitments are not immediately due. Investors pledge capital to private equity funds but typically hand over the cash only when general partners (GPs) issue capital calls to finance new deals, cover management fees, or fund follow-on investments in existing portfolio companies. The heightened risk for HMC is that these capital calls continue – or even intensify as GPs seek to support struggling portfolio companies – even as distributions from older, more mature funds slow to a trickle. This creates a dangerous liquidity squeeze.

Narvekar’s strategic mandate after joining HMC in 2016 was clear: aggressively increase its exposure to private markets. In an October 2019 letter, he articulated the endowment’s “central concern” that its “allocation to buyouts, growth, and venture capital continues to be low relative to what likely makes sense for Harvard.” This philosophy drove HMC’s allocation to private equity to a staggering 41 per cent by 2025, up from just 16 per cent in 2017 – a dramatic reorientation of its multi-billion-dollar portfolio.

The strategy initially appeared prescient, paying off handsomely during the unprecedented dealmaking boom of 2021, when HMC posted a record 33.6 per cent return. This period, characterized by ultra-low interest rates and soaring valuations, allowed private equity to thrive. However, this high exposure subsequently left the endowment acutely vulnerable to the sharp slowdown in exits that followed as higher interest rates and inflationary pressures weighed heavily on the IPO market and M&A activity. HMC reported a loss in 2022 and a modest 2.9 per cent return in 2023. While performance rebounded to near or above double digits over the following two years, Narvekar acknowledged in his 2025 annual letter that returns were “dampened by having less public than private equity” that continues to struggle with exit difficulties.

“HMC under Narvekar took higher risk and got lower return,” criticized Mark Williams, a lecturer at Boston University who has extensively studied HMC. “That’s just failure in proper and strong risk management.” This assessment resonates beyond Harvard, prompting a re-evaluation of the risk-return profile of illiquid alternatives in a changed macroeconomic environment.

The financial pressures on Harvard extend beyond its endowment’s portfolio. The university faces growing external pressures, including federal funding cuts and a higher excise tax on endowment income set to take effect in July. Given that Harvard relies on endowment payouts for more than a third of its operating revenue, the performance, and crucially, the liquidity of HMC’s portfolio have become paramount.

The challenge is stark when examining the endowment’s cash position. Cash alone, at 3 per cent of the endowment or roughly $1.7bn in its 2025 annual report, would be woefully insufficient to meet the $7.9bn in commitments if they were called in full. While these obligations are drawn down over time, and HMC does hold other liquid and semi-liquid assets—including public equities, bonds, and hedge fund allocations that it could tap—the potential for a significant asset-liability mismatch is clear. Forced sales of liquid assets at inopportune times could erode future returns.

This large, multiyear capital-call obligation now sits uncomfortably alongside rising university cash needs. The unfunded commitment, as Casey notes, “is a very significant liability at a time when Harvard is really having this challenge of matching their short-term cash flow needs with their long-term assets in the endowment.” He concludes, “They have this very significant asset-liability mismatch,” a sentiment echoed by many analyzing the state of large endowments today.

Hunter Lewis, who advised Harvard on the creation of HMC in the 1970s, offers a pointed recommendation for HMC’s next chief: focus less on chasing higher returns through illiquid alternatives and more on strategically cutting exposure to private markets. Instead, he advocates for holding a greater proportion of public equities and fixed-income assets that can be readily sold to meet growing cash needs. “You need liquidity to deal with whatever happens,” Lewis asserts, a principle gaining renewed importance in a volatile, higher-interest-rate world.

**Market Impact**

Harvard’s private markets dilemma is more than an isolated institutional challenge; it serves as a potent bellwether for the broader landscape of institutional investing. Many endowments, foundations, and pension funds globally pursued similar strategies of aggressive private equity allocation, particularly during the era of historically low interest rates. The liquidity crunch now facing HMC signals a potential industry-wide re-evaluation of the “endowment model” itself, prompting LPs to scrutinize their asset allocation, re-underwrite existing portfolios, and potentially scale back new commitments to private markets.

For the private equity industry, this could translate into a more challenging fundraising environment, increased pressure from LPs for distributions, and a greater emphasis on value creation within existing portfolio companies rather than solely new deal sourcing. The rising demand for liquidity could also invigorate the secondary market, as LPs seek avenues to offload unfunded commitments or existing fund stakes. Furthermore, the difficulties in exiting private assets will continue to fuel the ongoing debate about private market valuations, particularly their relationship to public market multiples. Ultimately, Harvard’s predicament is likely to drive a shift towards greater caution, an increased focus on liquidity and robust risk management, and perhaps a renewed appreciation for the flexibility and transparency offered by public market investments among institutional investors worldwide.